12
Participants
Start Date
February 24, 2023
Primary Completion Date
November 30, 2023
Study Completion Date
November 30, 2023
No Intervention
As this is an observational study, no intervention will be administered.
YolaRx Consultants, Montreal
Lead Sponsor
Takeda
INDUSTRY